These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33516446)

  • 21. Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1129. PubMed ID: 27869092
    [No Abstract]   [Full Text] [Related]  

  • 22. What is the target volume for preoperative accelerated partial breast irradiation (APBI)? In regards to Nichols et al. (Int J Radiat Oncol Biol Phys 2010;77:197-202) and Palta et al. (Int J Radiat Oncol Biol Phys 2010, in Press).
    Kim L; Shaitelman S
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):314-5; author reply 315-6. PubMed ID: 21481727
    [No Abstract]   [Full Text] [Related]  

  • 23. Erratum to: Zhongjie Chen, Yinshan Fang, Si Zhang, et al. Haplodeletion of Follistatin-Like 1 Attenuates Radiation-Induced Pulmonary Fibrosis in Mice. Int J Radiat Oncol Biol Phys 2019;103:208-216.
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):890. PubMed ID: 32092348
    [No Abstract]   [Full Text] [Related]  

  • 24. Erratum to: Woodward WA, Fang P, Arriaga L, et al. A phase 2 study of preoperative capecitabine and concomitant radiation in women with advanced breast cancer. Int J Radiat Oncol Biol Phys 2017;99:777-783.
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):497. PubMed ID: 29726371
    [No Abstract]   [Full Text] [Related]  

  • 25. Erratum to: Hafeez S, McDonald F, Lalondrelle S, et al. Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment. Int J Radiat Oncol Biol Phys 2017;98:115-122.
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):532-533. PubMed ID: 29353666
    [No Abstract]   [Full Text] [Related]  

  • 26. Erratum to: Reddy J, Lei X, Bloom S, et al. Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2024;115(3): 629-644.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1034. PubMed ID: 38851265
    [No Abstract]   [Full Text] [Related]  

  • 27. Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):1030-1031. PubMed ID: 38851263
    [No Abstract]   [Full Text] [Related]  

  • 28. Erratum to: Ho AY, Olm-Shipman M, Zhang Z, et al. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys 2018;101;325-333.
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):231. PubMed ID: 30102200
    [No Abstract]   [Full Text] [Related]  

  • 29. Erratum to: Gunther JR, Jimenez RB, Yechieli RL, et al. Introductory Radiation Oncology Curriculum: Report of a National Needs Assessment and Multi-institutional Pilot Implementation. Int J Radiat Oncol Biol Phys 2018;101:1029-1038.
    Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1602. PubMed ID: 31014796
    [No Abstract]   [Full Text] [Related]  

  • 30. Erratum to: Rodrigues G, Oberije C, Senan S, et al. is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small cell lung cancer beneficial? A multi-institutional propensity score matched analysis. Int J Radiat Oncol Biol Phys 2015;91:133-139.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832709
    [No Abstract]   [Full Text] [Related]  

  • 31. What approach will lead to cure of glioblastoma multiforme? In regard to Barani et al. (Int J Radiat Oncol Biol Phys 2007;68:324-333) and Jones and Sanghera (Int J Radiat Oncol Biol Phys 2007;68:441-448).
    Nieder C
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):640-1; author reply 641. PubMed ID: 17869682
    [No Abstract]   [Full Text] [Related]  

  • 32. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 33. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271).
    Kavanagh BD; Newman F
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788
    [No Abstract]   [Full Text] [Related]  

  • 34. Erratum to: Dawei Chen, Vivek Verma, Roshal R. Patel, et al. Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials. Int J Radiat Oncol Biol Phys 2020:108(1);196-203.
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):623. PubMed ID: 33989592
    [No Abstract]   [Full Text] [Related]  

  • 35. Erratum to: Hao Y, Ran Y, Lu B, et al. Therapeutic Effects of Human Umbilical Cord-derived Mesenchymal Stem Cells on Canine Radiation-Induced Lung Injury. Int J Radiat Oncol Biol Phys 2018;102:407-416.
    Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):287. PubMed ID: 30563665
    [No Abstract]   [Full Text] [Related]  

  • 36. Erratum to: Kong X-T, Nguyen NT, Choi YJ, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. Int J Radiat Oncol Biol Phys 2018;100:1195-1203.
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1289. PubMed ID: 30900570
    [No Abstract]   [Full Text] [Related]  

  • 37. Erratum to: Wallner PE, Anscher MS, Barker CA, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys 2014;88:11-17.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832710
    [No Abstract]   [Full Text] [Related]  

  • 38. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).
    Komaki R; Liao Z; Liu H; Tucker S; Rice D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1595-6; author reply 1596. PubMed ID: 17126220
    [No Abstract]   [Full Text] [Related]  

  • 39. Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
    McKenna F; Ahmad S
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):640; author reply 640-1. PubMed ID: 19147035
    [No Abstract]   [Full Text] [Related]  

  • 40. Erratum to Ringash J, Fisher R, Peters L, et al. Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 2017;97:678-686.
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):244. PubMed ID: 28816156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.